Shares of Novo Nordisk and Eli Lilly & Co. dropped early Tuesday after President Joe Biden and Sen. Bernie Sanders took aim at obesity and diabetes drug prices in a USA Today opinion piece.
Novo Nordisk, Eli Lilly singled out by Biden, Sanders over drug prices
